Literature for IDE inhibitor 1 (M16.002 inhibitor)

(Topics flags: S Structure, I Inhibitor. To select only the references relevant to a single topic, click the link above. See explanation.)

2014
1. Kurklinsky,S., Abdul-Hay,S.O., McGuire,M.P., Howard,E.A., Knight,J. and Leissring,M.A.
   The blood glucose-lowering effect of racecadotril is not attributable to inhibition of insulin-degrading enzyme
   Horm Metab Res46, 73-74. PubMed  Europe PubMed DOI  I
2. Maianti,J.P., McFedries,A., Foda,Z.H., Kleiner,R.E., Du,X.Q., Leissring,M.A., Tang,W.J., Charron,M.J., Seeliger,M.A., Saghatelian,A. and Liu,D.R.
   Anti-diabetic activity of insulin-degrading enzyme inhibitors mediated by multiple hormones
   Nature511, 94-98. PubMed  Europe PubMed DOI  S  I
2010
3. Leissring,M.A., Malito,E., Hedouin,S., Reinstatler,L., Sahara,T., Abdul-Hay,S.O., Choudhry,S., Maharvi,G.M., Fauq,A.H., Huzarska,M., May,P.S., Choi,S., Logan,T.P., Turk,B.E., Cantley,L.C., Manolopoulou,M., Tang,W.J., Stein,R.L., Cuny,G.D. and Selkoe,D.J.
   Designed inhibitors of insulin-degrading enzyme regulate the catabolism and activity of insulin
   PLoS ONE5, e10504-e10504. PubMed  Europe PubMed DOI  S  I